Chemical formula: C₂₁H₂₀FN₃O₆S Molecular mass: 461.46 g/mol PubChem compound: 65947
Prulifloxacin is indicated for:
Population group: only adults (18 years old or older)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Acute bacterial sinusitis should be adequately diagnosed according to the National or local guidelines on the treatment of respiratory infections. For the treatment of bacterial rhinosinusitis, prulifloxacin should be used only in patients with a duration of symptoms less than 4 weeks, and when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection or when have failed to resolve the infection.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Prulifloxacin is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
